Ann De Becker

Universitair Ziekenhuis Brussel
Brussels, BRU, BE 
Universitair Ziekenhuis Brussel
Brussels, BRU, BE 

Overview

Ann De Becker practices practicing medicine in Brussels, Belgium.

Her clinical expertise encompasses Multiple Myeloma, Acute Myeloid Leukemia (AML), WT1-Related Wilms Tumor Syndromes, Leukemia, and Bone Marrow Transplant.

She is actively involved in clinical research, co-authoring 54 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Universitair Ziekenhuis Brussel
Brussels, BRU, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Randomized Study of Zanubrutinib (BGB-3111) Compared With Ibrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
A Phase 3, Randomized Study of Zanubrutinib (BGB-3111) Compared With Ibrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Enrollment Status: Completed
Publish Date: March 30, 2025
Intervention Type: Drug
Study Drugs: Zanubrutinib, Ibrutinib
Study Phase: Phase 3
A Multicenter Observational Belgian Study Assessing the Impact of Newly Started Treatment on the QOL in Patients Suffering From Myelodysplastic Syndromes.
A Multicenter Observational Belgian Study Assessing the Impact of Newly Started Treatment on the QOL in Patients Suffering From Myelodysplastic Syndromes.
Enrollment Status: Completed
Publish Date: March 30, 2025
View 1 Less Clinical Trial

54 Total Publications

Adrenergic stimulation of bone marrow immunity differentially affects myeloma growth and immunotherapy responses.
Adrenergic stimulation of bone marrow immunity differentially affects myeloma growth and immunotherapy responses.
Journal: Cancer letters
Published: April 15, 2026

Frequently Asked Questions about Ann De Becker

Is Ann De Becker a top-rated expert for Multiple Myeloma?

MediFind is an objective health platform that identifies experts based on real-world data. Ann De Becker is classified as an Experienced expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ann De Becker participate in research or clinical trials?

Yes. Ann De Becker has published 54 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Ann De Becker's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. De Becker's expertise for a condition
ConditionClose
        View All 15 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile